Company: SHPH
Filing Date: 2025-02-27
Form Type: 424B3
Source: 0001493152-25-008476
Chunk: 140

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-27
Form: 424B3
Chunk 140
---
, international background, gender and age when evaluating candidates for board of directors membership.

Further, the nominating and corporate governance committee, to the extent it deems necessary or appropriate, among its several other responsibilities will:

| ● | recommend                                                                                                                                  
 to the board of directors and for approval by a majority of independent directors for election by stockholders or appointment by           
 the board of directors as the case may be, pursuant to our bylaws and consistent with the board of director’s evidence for                 
 selecting new directors;                                                                                                                   |
| ● | review                                                                                                                                     
 the suitability for continued service as a director of each member of the board of directors when his or her term expires or when          
 he or she has a significant change in status;                                                                                              |
| ● | review                                                                                                                                     
 annually the composition of the board of directors and to review periodically the size of the board of directors;                          |
| ● | make                                                                                                                                       
 recommendations on the frequency and structure of board of directors meetings or any other aspect of procedures of the board of directors; |
| ● | make                                                                                                                                       
 recommendations regarding the chairmanship and composition of standing committees and monitor their functions;                             |
| ● | review                                                                                                                                     
 annually committee assignments and chairmanships;                                                                                          |
| ● | recommend                                                                                                                                  
 the establishment of special committees as may be necessary or desirable from time to time; and                                            |
| ● | develop                                                                                                                                    
 and periodically review corporate governance procedures and consider any other corporate governance issue.                                 |

Code of Ethics

We have adopted a code of ethics that applies to all of our executive officers, directors and employees. The code of ethics codifies the business and ethical principles that govern all aspects of our business. This document will be made available in print, free of charge, to any stockholder requesting a copy in writing from our secretary at our executive offices in Gaithersburg, Maryland. A copy of our code of ethics is available on our website at www.shuttlepharma.com.

| 77 |

Insider Trading Policies and Procedures

The Company has adopted an insider trading policy, as amended and restated on March 10, 2023 (the “Insider Trading Policy”), overseen by the Company’s corporate secretary, that applies to all (i) directors, (ii) executive officers and (iii) employees who are exposed to insider information (together, the “Covered Persons”). The Insider Trading Policy prohibits the use of material non-public information obtained by Covered Persons through their involvement with the Company when making decisions to purchase, sell, give